Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.

@article{Gao2015EfficacyAS,
  title={Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.},
  author={Zhenli Gao and Diandong Yang and Luxin Yu and Yuanshan Cui},
  journal={The journal of sexual medicine},
  year={2015},
  volume={12 11},
  pages={
          2095-104
        }
}
INTRODUCTION Flibanserin, is a postsynaptic agonist of serotonin receptor 1A and an antagonist of serotonin receptor 2A, has been shown to increase sexual desire and reduce distress in women with hypoactive sexual desire disorder (HSDD). AIM We carried out a systematic review and meta-analysis to assess the efficacy and safety of the drug in women with HSDD. METHODS A literature review was performed to identify all published randomized double-blind, placebo-controlled trials of flibanserin… CONTINUE READING
12
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Pharmacological Advances in the Management of Sexual Dysfunction

  • Indian journal of psychological medicine
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND